Ceft Biopharma

Ceft Biopharma is a specialty pharmaceutical company based in Pune, India, that focuses on the development and manufacturing of complex drug delivery systems. The company utilizes proprietary technology platforms in liposomes, nanoparticles, and emulsions to enhance the efficacy and safety profiles of critical care and oncology medications. Their portfolio includes advanced formulations of established therapeutic agents such as amphotericin B and doxorubicin, targeting high-barrier-to-entry generic markets. In addition to its internal product pipeline, Ceft Biopharma operates as a Contract Development and Manufacturing Organization (CDMO), offering specialized services from formulation R&D to commercial-scale sterile injectable production. The company's facilities are designed to meet international regulatory standards, positioning them as a key player in the global complex generics landscape.